SHL’s COVID-19 Statement regarding Taiwan’s case
The recent surge of COVID cases in Taiwan has prompted SHL Medical to take action on tightening the precautionary COVID restrictions in Taiwan’s office and production sites, following the government’s decision to raise the pandemic alert warning. Since the outbreak of the pandemic, the company has taken proactive measures to protect the health and safety of our staff and ensure the continuity of drug delivery products for our customers and end-users.
Our manufacturing, supply, and office work maintain regular operations under the precautionary measures we have implemented to help reduce human contact. We are constantly tracking the government’s policies concerning COVID developments, so as to adapt and make adjustments to our manpower allocation or shift schedules.
To this end, we have worked tirelessly and relentlessly to ensure business continuity, as well as preventing the potential spread of COVID within company quarters. Our frequent travel history survey and on-site infirmary staff support us in tracking colleagues’ health and safety.
Our aim is to continue business operations while still providing quality service to our customers during such critical times.
